SENGENICS
Sengenics is a functional proteomics company that leverages its patented KREXâ„¢ technology for production of full-length, correctly folded and functional proteins. KREXâ„¢ was invented and patented by Professor Jonathan Blackburn whilst he was a member of the faculty at the University of Cambridge. Jonathan is the CSO of Sengenics. The key application of KREXâ„¢ is the discovery of autoantibody biomarkers for two core medical use cases. Firstly, stratification of patients undergoing treatment ... with autoimmune or cancer drugs into responders, non-responders and those that may exhibit severe immune-related adverse events. Secondly, identification of autoantibody biomarkers that may be used to diagnose cancer, autoimmune or neurodegenerative conditions years before conventional diagnostic tests.
SENGENICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
1996-01-01
Address:
Singapore, Central Region, Singapore
Country:
Singapore
Website Url:
http://www.sengenics.com
Total Employee:
101+
Status:
Active
Contact:
+44 (0) 1223 92 6588
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Google Tag Manager WordPress Font Awesome Domain Not Resolving Wordpress Plugins
Current Employees Featured
Founder
Investors List
Cancer Research UK
Cancer Research UK investment in Grant - Sengenics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-09-07 | Sengenics Prepares for Next Phase Growth and Welcomes Bioscience Industry Leader as New CEO |
Official Site Inspections
http://www.sengenics.com Semrush global rank: 9.26 M Semrush visits lastest month: 186
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
